Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction
Author(s) -
Henning Kelbæk,
Leif Thuesen,
Steffen Helqvist,
Peter Clemmensen,
Lene Kløvgaard,
Anne Kaltoft,
Bente Andersen,
Helle Thuesen,
Thomas Engstrøm,
Hans Erik Bøtker,
Kari Saunamäki,
Lars Romer Krusell,
Erik Jørgensen,
Hans-Henrik Tilsted Hansen,
Evald Høj Christiansen,
Jan Ravkilde,
Lars Køber,
Klaus F. Kofoed,
Christian Juhl Terkelsen,
Jens Flensted Lassen
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.758698
Subject(s) - medicine , percutaneous coronary intervention , cardiology , myocardial infarction , restenosis , stent , bare metal stent , drug eluting stent , coronary artery disease , revascularization
Implantation of drug-eluting stents (DES) limits the rate of coronary restenosis in most patients with coronary artery disease, but data are scarce with regard to their use in patients with ST-segment-elevation myocardial infarction and in connection with distal protection of the microvascular perfusion during primary percutaneous coronary intervention.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom